FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Investigation of omeprazole stability in oral suspensions for pediatric use prepared extemporaneously from omeprazole capsules

Ispitivanje stabilnosti oralnih suspenzija omeprazola za pedijatrijsku primenu magistralno izrađenih iz omeprazol kapsula

Thumbnail
2017
2941.pdf (321.3Kb)
Authors
Milić, Jela
Radojković, Branko
Jančić-Stojanović, Biljana
Drašković, Jasmina
Mirašević, Slavica
Čalija, Bojan
Article (Published version)
Metadata
Show full item record
Abstract
In this paper, a study exploring the stability of omeprazole in pediatric suspensions is presented. In order to determine the most suitable suspension, three different formulations were prepared and stored under refrigerated conditions and at room temperature for 30 days. Contents of omeprazole and preservatives were determined by liquid chromatographic method. Obtained results demonstrate that the vehicle consisting of: xanthan gum 0.3%, sodium bicarbonate 8%, Compound hydroxybenzoate solution APF 1% and purified water to 100% could have a significant potential in the development of a suitable omeprazole oral liquid for pediatric use. Namely, the content of omeprazole in the suspension prepared with this vehicle remained within acceptable range during the 30-day period, when stored refrigerated (2-8°C).
U ovom radu predstavljeno je ispitivanje stabilnosti omeprazola u suspenzijama za pedijatrijsku primenu, koje su izrađene iz komercijalno dostupnih kapsula omeprazola u uslovima apoteke. U cilju utvrđivanja najpogodnijeg vehikuluma za magistralnu izradu suspenzija omeprazola, pripremljene su tri formulacije, koje su potom 30 dana čuvane u frižideru i na sobnoj temperaturi. Sadržaj omeprazola i konzervansa u suspenzijama je određivan primenom tečne hromatografije. Dobijeni rezultati ukazuju da vehikulum koji se sastoji iz ksantan gume 0,3%, natrijum-bikarbonata 8%, rastvora parabena 1% (Compound hydroxybenzoate solution APF) i prečišćene vode do 100% ima značajan potencijal za razvoj pogodnog tečnog oblika omeprazola za peroralnu primenu u pedijatrijskoj populaciji. Naime, sadržaj omeprazola u suspenziji pripremljenoj primenom ovog vehikuluma je ostao u okviru prihvatljivih granica tokom perioda od 30 dana, kada je suspenzija čuvana u frižideru (2-8°C).
Keywords:
omeprazole / stability / pediatric suspension / liquid chromatography / omeprazol / stabilnost / suspenzija za pedijatrijsku primenu / tečna hromatografija
Source:
Arhiv za farmaciju, 2017, 67, 1, 14-25
Publisher:
  • Savez farmaceutskih udruženja Srbije, Beograd

DOI: 10.5937/arhfarm1701014M

ISSN: 0004-1963

Scopus: 2-s2.0-85025154295
[ Google Scholar ]
4
URI
https://farfar.pharmacy.bg.ac.rs/handle/123456789/2943
Collections
  • Radovi istraživača / Researchers’ publications
Institution/Community
Pharmacy
TY  - JOUR
AU  - Milić, Jela
AU  - Radojković, Branko
AU  - Jančić-Stojanović, Biljana
AU  - Drašković, Jasmina
AU  - Mirašević, Slavica
AU  - Čalija, Bojan
PY  - 2017
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2943
AB  - In this paper, a study exploring the stability of omeprazole in pediatric suspensions is presented. In order to determine the most suitable suspension, three different formulations were prepared and stored under refrigerated conditions and at room temperature for 30 days. Contents of omeprazole and preservatives were determined by liquid chromatographic method. Obtained results demonstrate that the vehicle consisting of: xanthan gum 0.3%, sodium bicarbonate 8%, Compound hydroxybenzoate solution APF 1% and purified water to 100% could have a significant potential in the development of a suitable omeprazole oral liquid for pediatric use. Namely, the content of omeprazole in the suspension prepared with this vehicle remained within acceptable range during the 30-day period, when stored refrigerated (2-8°C).
AB  - U ovom radu predstavljeno je ispitivanje stabilnosti omeprazola u suspenzijama za pedijatrijsku primenu, koje su izrađene iz komercijalno dostupnih kapsula omeprazola u uslovima apoteke. U cilju utvrđivanja najpogodnijeg vehikuluma za magistralnu izradu suspenzija omeprazola, pripremljene su tri formulacije, koje su potom 30 dana čuvane u frižideru i na sobnoj temperaturi. Sadržaj omeprazola i konzervansa u suspenzijama je određivan primenom tečne hromatografije. Dobijeni rezultati ukazuju da vehikulum koji se sastoji iz ksantan gume 0,3%, natrijum-bikarbonata 8%, rastvora parabena 1% (Compound hydroxybenzoate solution APF) i prečišćene vode do 100% ima značajan potencijal za razvoj pogodnog tečnog oblika omeprazola za peroralnu primenu u pedijatrijskoj populaciji. Naime, sadržaj omeprazola u suspenziji pripremljenoj primenom ovog vehikuluma je ostao u okviru prihvatljivih granica tokom perioda od 30 dana, kada je suspenzija čuvana u frižideru (2-8°C).
PB  - Savez farmaceutskih udruženja Srbije, Beograd
T2  - Arhiv za farmaciju
T1  - Investigation of omeprazole stability in oral suspensions for pediatric use prepared extemporaneously from omeprazole capsules
T1  - Ispitivanje stabilnosti oralnih suspenzija omeprazola za pedijatrijsku primenu magistralno izrađenih iz omeprazol kapsula
VL  - 67
IS  - 1
SP  - 14
EP  - 25
DO  - 10.5937/arhfarm1701014M
ER  - 
@article{
author = "Milić, Jela and Radojković, Branko and Jančić-Stojanović, Biljana and Drašković, Jasmina and Mirašević, Slavica and Čalija, Bojan",
year = "2017",
abstract = "In this paper, a study exploring the stability of omeprazole in pediatric suspensions is presented. In order to determine the most suitable suspension, three different formulations were prepared and stored under refrigerated conditions and at room temperature for 30 days. Contents of omeprazole and preservatives were determined by liquid chromatographic method. Obtained results demonstrate that the vehicle consisting of: xanthan gum 0.3%, sodium bicarbonate 8%, Compound hydroxybenzoate solution APF 1% and purified water to 100% could have a significant potential in the development of a suitable omeprazole oral liquid for pediatric use. Namely, the content of omeprazole in the suspension prepared with this vehicle remained within acceptable range during the 30-day period, when stored refrigerated (2-8°C)., U ovom radu predstavljeno je ispitivanje stabilnosti omeprazola u suspenzijama za pedijatrijsku primenu, koje su izrađene iz komercijalno dostupnih kapsula omeprazola u uslovima apoteke. U cilju utvrđivanja najpogodnijeg vehikuluma za magistralnu izradu suspenzija omeprazola, pripremljene su tri formulacije, koje su potom 30 dana čuvane u frižideru i na sobnoj temperaturi. Sadržaj omeprazola i konzervansa u suspenzijama je određivan primenom tečne hromatografije. Dobijeni rezultati ukazuju da vehikulum koji se sastoji iz ksantan gume 0,3%, natrijum-bikarbonata 8%, rastvora parabena 1% (Compound hydroxybenzoate solution APF) i prečišćene vode do 100% ima značajan potencijal za razvoj pogodnog tečnog oblika omeprazola za peroralnu primenu u pedijatrijskoj populaciji. Naime, sadržaj omeprazola u suspenziji pripremljenoj primenom ovog vehikuluma je ostao u okviru prihvatljivih granica tokom perioda od 30 dana, kada je suspenzija čuvana u frižideru (2-8°C).",
publisher = "Savez farmaceutskih udruženja Srbije, Beograd",
journal = "Arhiv za farmaciju",
title = "Investigation of omeprazole stability in oral suspensions for pediatric use prepared extemporaneously from omeprazole capsules, Ispitivanje stabilnosti oralnih suspenzija omeprazola za pedijatrijsku primenu magistralno izrađenih iz omeprazol kapsula",
volume = "67",
number = "1",
pages = "14-25",
doi = "10.5937/arhfarm1701014M"
}
Milić, J., Radojković, B., Jančić-Stojanović, B., Drašković, J., Mirašević, S.,& Čalija, B.. (2017). Investigation of omeprazole stability in oral suspensions for pediatric use prepared extemporaneously from omeprazole capsules. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije, Beograd., 67(1), 14-25.
https://doi.org/10.5937/arhfarm1701014M
Milić J, Radojković B, Jančić-Stojanović B, Drašković J, Mirašević S, Čalija B. Investigation of omeprazole stability in oral suspensions for pediatric use prepared extemporaneously from omeprazole capsules. in Arhiv za farmaciju. 2017;67(1):14-25.
doi:10.5937/arhfarm1701014M .
Milić, Jela, Radojković, Branko, Jančić-Stojanović, Biljana, Drašković, Jasmina, Mirašević, Slavica, Čalija, Bojan, "Investigation of omeprazole stability in oral suspensions for pediatric use prepared extemporaneously from omeprazole capsules" in Arhiv za farmaciju, 67, no. 1 (2017):14-25,
https://doi.org/10.5937/arhfarm1701014M . .

Related items

Showing items related by title, author, creator and subject.

  • Stability studies of omeprazole and omeprazole-cyclodextrin inclusion complexes at different PH values / Studije stabilnosti omeprazola i njegovih inkluzionih kompleksa sa ciklodekstrinom pri različitim PH vrednostima 

    Agatonović-Kuštrin, Snežana; Zečević, Mira; Jocić, Biljana (Savez farmaceutskih udruženja Srbije, Beograd, 2006)
  • Investigation of omeprazole stability in oral suspensions for pediatric use prepared extemporaneously from omeprazole capsules 

    Milić, Jela; Radojković, Branko; Stojanović, Biljana; Drašković, Jasmina; Mirašević, Slavica; Đorđević, Sanela (Elsevier Science BV, Amsterdam, 2016)
  • Interaction between Omeprazole and Gliclazide in Relation to CYP2C19 Phenotype 

    Dujić, Tanja; Cvijić, Sandra; Elezović, Amar; Bego, Tamer; Imamović Kadrić, Selma; Malenica, Maja; Elezović, Alisa; Pearson, Ewan R.; Kulo, Aida (MDPI, 2021)

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB